SCHEMBL16423909

SCHEMBL16423909

COc1ccc2c(c1)c(=O)[nH]n2-c1cccc(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
CYP1A2 P05177 1/20 0.49
HPGD P15428 1/20 0.49
CYP2C19 P33261 1/20 0.49
PDE11A Q9HCR9 1/20 0.44
KCNH2 Q12809 1/20 0.43
ALKBH5 Q6P6C2 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
GABRA1 P14867 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
NPBWR1 P48145 1/20 0.42
MCHR1 Q99705 1/20 0.42
GABRA2 P47869 1/20 0.42
MAP4K4 O95819 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638428 0.77 CYP1A2 (0.44) KMT2AMEN1MAPTCYP1A2HPGD
SCHEMBL29638406 0.71 CYP1A2 (0.43) KMT2AMEN1MAPTCYP1A2HPGD
SCHEMBL29638496 0.69 SRC (0.46) KMT2AMEN1MAPTCYP1A2KCNH2
SCHEMBL24557271 0.69 SRC (0.46) KMT2AMEN1MAPTCYP1A2KCNH2
SCHEMBL29638411 0.69 ALKBH5 (0.42) KMT2AMEN1MAPTCYP1A2PDE11A
SCHEMBL24557279 0.67 MEN1 (0.42) KMT2AMEN1MAPTCYP1A2HPGD
SCHEMBL22093161 0.67 MAT2A (0.65) KMT2AMEN1MAPTCYP1A2HPGD
SCHEMBL30476312 0.67 MAT2A (0.65) KMT2AMEN1MAPTCYP1A2HPGD
SCHEMBL8171501 0.67 FNTA (0.53) KMT2AMEN1MAPTHPGDRXFP1
SCHEMBL28011551 0.66 TP53 (0.49) KMT2AMEN1MAPTCYP1A2ALKBH5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045551-A1 FUSED AZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2015-02-12 US disclosed
US-20150045551-A1 FUSED AZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2015-02-12 US disclosed
US-20150045551-A1 FUSED AZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2015-02-12 US disclosed
EP-2832722-A1 FUSED AZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2015-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045551-A1 FUSED AZOLE DERIVATIVE AVPR1B, AVPR1A, GRIN2B KMT2A 1627/4885MEN1 1176/4885MAPT 825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.